CONTACT US
Home > Inhibitors/Agonists> > Endoxifen E-isomer
Endoxifen E-isomer

Endoxifen E-isomer

  • CAT Number: I000552
  • CAS Number: 114828-90-9
  • Molecular Formula: C25H27NO2
  • Molecular Weight: 373.49
  • Purity: ≥95%
Inquiry Now

Endoxifen E-isomer (Cat.No:I000552) is a metabolite of tamoxifen and exhibits potent antiestrogenic activity. It acts by binding to estrogen receptors and inhibiting their activation, making it valuable in the treatment of hormone receptor-positive breast cancer. Endoxifen E-isomer offers a potential therapeutic option for patients resistant to tamoxifen therapy.

Catalog Number I000552
CAS Number 114828-90-9
Molecular Formula

C25H27NO2

Purity 95%
Solubility DMSO: ≥ 32 mg/mL
Storage Store at -20°C
IUPAC Name 4-[(E)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
InChI InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24+
InChIKey MHJBZVSGOZTKRH-OCOZRVBESA-N
SMILES CC/C(=C(/C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3
Reference

<p>
<br />
[1]. Elkins P, et al. Characterization of the isomeric configuration and impurities of (Z)-Endoxifen by 2D NMR, high resolution LC-MS, and quantitative HPLC analysis. J Pharm Biomed Anal. 2014 Jan;88:174-9.
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!